Biomimetic Breast Implant Textures for Capsular Contracture Control
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current breast implants face challenges with capsular contracture and adverse cellular responses due to the formation of fibrous capsules, which can lead to implant failure and complications such as firmness, deformation, and pain, and are difficult to address with existing textured surface designs that often result in excessive tissue ingrowth and surgical trauma.
Innovation Solution
The development of biomimetic textured surface topographies for implants that mimic the surface features of human skin, specifically controlling macro, micro, and nano-scale roughness to promote desirable cellular responses, reduce capsular contraction, and facilitate easier implant removal by minimizing tissue ingrowth.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If textured silicone implant surfaces are used to reduce capsular contracture, then the incidence of capsular contracture is lowered, but excessive tissue ingrowth occurs leading to surgical trauma during removal
Solution Approach 1:
The implant surface features controlled macro-roughness (5-50 μm) in specific patterns rather than uniform texture, creating zones of varying roughness that promote desirable tissue integration while preventing excessive ingrowth. This localized quality control allows different regions to serve different functions.
Solution Approach 2:
The patent specifies precise parameter ranges for surface roughness (5-50 μm macro-roughness) and pore size (10-100 μm) to optimize the balance between preventing capsular contracture and minimizing tissue ingrowth. These controlled parameters distinguish the invention from conventional heavily textured surfaces.
2Reliability
If heavily textured implant surfaces are used to disrupt parallel collagen fibre formation, then capsular contraction is prevented, but surgical removal becomes more traumatic with excessive tissue loss
Solution Approach 1:
By controlling the surface roughness within specific ranges (5-50 μm macro-roughness, 10-100 μm pores) rather than using heavy texturing, the implant prevents capsular contraction while minimizing tissue ingrowth to levels that do not cause excessive loss during surgical removal.
Solution Approach 2:
The patent applies a moderate level of surface texturing that is sufficient to disrupt parallel collagen fibre formation and prevent capsular contraction, but not so excessive as to cause problematic tissue ingrowth. This partial action achieves the necessary effect without over-treatment.
Data Source
Figure 1~2
Figure 3~4
Figure 5~6
AI summary
The invention provides new devices for implantation in a patient having irregular textured surfaces, which devices show significantly improved cellular response compared to conventional smooth and textured implants, indicating that significantly improved biocompatibility would be achieved in vivo. Methods for making such new devices and surface textures are also disclosed.